| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CYRX | Common Stock | Options Exercise | $162K | +50K | +437.94% | $3.24* | 61.4K | Jul 15, 2021 | Direct | F1 |
| transaction | CYRX | Common Stock | Sale | -$671K | -12.7K | -20.74% | $52.73 | 48.7K | Jul 15, 2021 | Direct | F1, F2 |
| transaction | CYRX | Common Stock | Sale | -$899K | -16.7K | -34.4% | $53.70 | 31.9K | Jul 15, 2021 | Direct | F1, F3 |
| transaction | CYRX | Common Stock | Sale | -$688K | -12.6K | -39.31% | $54.79 | 19.4K | Jul 15, 2021 | Direct | F1, F4 |
| transaction | CYRX | Common Stock | Sale | -$443K | -7.97K | -41.09% | $55.59 | 11.4K | Jul 15, 2021 | Direct | F1, F5 |
| transaction | CYRX | Common Stock | Options Exercise | $96K | +20K | +175.18% | $4.80 | 31.4K | Jul 16, 2021 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CYRX | Options to purchase common stock | Options Exercise | $0 | -50K | -71.51% | $0.00 | 19.9K | Jul 15, 2021 | Common Stock | 50K | $3.24 | Direct | F1, F6 |
| transaction | CYRX | Options to purchase common stock | Options Exercise | $0 | -20K | -27.27% | $0.00 | 53.3K | Jul 16, 2021 | Common Stock | 20K | $4.80 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2021. |
| F2 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.34 to $53.33, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.34 to $54.32, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.35 to $55.34, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.35 to $56.075, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F6 | Options vested on the 28th of each month for 48 months beginning on July 28, 2013. |
| F7 | Options vested on the 18th of each month for 48 months beginning on January 18, 2015. |